Ming-yang Hung in Omaha, Nebraska

Home Nebraska Omaha

Ming-yang Hung has Radiation Oncology as his primary medical specialty. Their primary office is: 8303 Dodge St in Omaha, Nebraska. There are 2 additional office locations for Ming-yang Hung that can be viewed towards the end of their profile.

They're a part of the: Nebraska Methodist Hospital medical group which has around 120 members. You can call their office at 402-354-4104 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Georgetown University School Of Medicine and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ming-yang Hung Office Phone and Directions

Ming-yang Hung
Nebraska Methodist Hospital
8303 Dodge St
Omaha, Nebraska 68114
402-354-4104

Patient Ratings
Please rate your experience with Ming-yang Hung below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 402-354-4104

Enter a starting address:

Healthcare Info for Ming-yang Hung

Medical School: Georgetown University School Of Medicine
Graduation Year: 2018
The Primary Medical Specialty for Ming-yang Hung is listed as: Radiation Oncology
Approximate Years of Experience: 6
PAC (PECOS ID)#: 0143552372
NPI #: 1043715352
NPI Created On: 03/28/2018
NPI Last Updated Listed as: 03/02/2023
Primary Taxonomy Code: 390200000X
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829968609

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: IMFINZI

Open Associated Drug #1: 0310-4500-12